Left ventricular mass index as an outcome measure in clinical trials in dialysis patients: A word of caution

American Journal of Nephrology

Volumn 33, Issue 4, 2011, Pages 370-372

  Zoccali, Carmine ^a,b  

^a CNR Consiglio Nazionale delle Ricerche   (Italy)

^b BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANEMIA; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CLINICAL TRIAL (TOPIC); DISEASE ASSOCIATION; EDITORIAL; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART VENTRICLE SEPTUM; HEMODIALYSIS; HEMODIALYSIS PATIENT; HIGH RISK POPULATION; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; SALT INTAKE; WEIGHT REDUCTION;

CLINICAL TRIALS AS TOPIC; HEART VENTRICLES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; NEPHROLOGY; RENAL DIALYSIS; TREATMENT OUTCOME;

EID: 79953046977     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000326239     Document Type: Editorial

References (12)

1. Devereux RB, de Simone G, Ganau A, Roman MJ: Left ventricular hypertrophy and geometric remodeling in hypertension: stimuli, functional consequences and prognostic implications. J Hypertens Suppl 1994; 12:S117-S127.
2. Muiesan ML, Salvetti M, Rizzoni D, Monteduro C, Castellano M, Agabiti-Rosei E: Persistence of left ventricular hypertrophy is a stronger indicator of cardiovascular events than baseline left ventricular mass or systolic performance: 10 years of follow-up. J Hypertens Suppl 1996; 14:S43-S49.
3. Drazner MH: The progression of hypertensive heart disease. Circulation 2011; 123: 327-334.
4. Muiesan ML, Salvetti M, Monteduro C, Bonzi B, Paini A, Viola S, Poisa P, Rizzoni D, Castellano M, Agabiti-Rosei E: Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients. Hypertension 2004; 43: 731-738.
5. Foley RN, Parfrey PS: Cardiac disease in chronic uremia: clinical outcome and risk factors. Adv Ren Replace Ther 1997; 4: 234-248.
6. Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Cataliotti A, Seminara G, Stancanelli B, Malatino LS: Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis. J Am Soc Nephrol 2001; 12: 2768-2774.
7. Culleton BF, Walsh M, Klarenbach SW, Mortis G, Scott-Douglas N, Quinn RR, Tonelli M, Donnelly S, Friedrich MG, Kumar A, Mahallati H, Hemmelgarn BR, Manns BJ: Effect of frequent nocturnal hemodialysis vs. conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA 2007; 298: 1291-1299.
8. Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, Gassman JJ, Gorodetskaya I, Greene T, James S, Larive B, Lindsay RM, Mehta RL, Miller B, Ornt DB, Rajagopalan S, Rastogi A, Rocco MV, Schiller B, Sergeyeva O, Schulman G, Ting GO, Unruh ML, Star RA, Kliger AS: In-center hemodialysis six times per week versus three times per week. N Engl J Med 2010; 363: 2287-2300.
9. Agarwal R, Bouldin J, Light R, Garg A: Probing dry-weight improves left ventricular mass index; Am J Nephrol 2011;33:373-380.
10. Agarwal R, Alborzi P, Satyan S, Light RP: Dry-weight Reduction In hypertensive hemodialysis Patients (DRIP): a randomized, controlled trial. Hypertension 2009; 53: 500-507.
11. Flythe JE, Kimmel SE, Brunelli SM: Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality. Kidney Int 2011; 79: 250-257.
12. Ozkahya M, Toz H, Qzerkan F, Duman S, Ok E, Basci A, Mees EJ: Impact of volume control on left ventricular hypertrophy in dialysis patients. J Nephrol 2002; 15: 655-660.